Latest news with #PrecisionMedicine
Associated Press
6 days ago
- Health
- Associated Press
Big Data in Healthcare Market Trends and Forecast Report 2025-2035, with Leading Players
DUBLIN--(BUSINESS WIRE)--Aug 7, 2025-- The 'Big Data in Healthcare Market Trends and Forecast Report 2025-2035: By Component, Type of Hardware, Type of Software and Service, Deployment Option, Application Area, Healthcare Vertical, End User, Economic Status, Geography and Leading Players' report has been added to offering. The global big data in healthcare market is estimated to grow from USD 78 billion in 2025, to USD 540 billion by 2035, at a CAGR of 19.20% during the forecast period, to 2035. The integration of big data analytics in the healthcare domain holds immense potential for revolutionizing the industry and unlocking lucrative business opportunities for service providers. The ability to aggregate, analyze, and derive actionable insights from vast amounts of data can enhance clinical decision-making, optimize resource allocation, and improve patient outcomes. Moreover, the integration of predictive analytics and machine learning algorithms with big data can enable early detection of diseases, personalized treatment plans, and precision medicine. This paradigm shift offers service providers the chance to develop innovative solutions, such as cloud-based platforms for real-time monitoring systems, and data-driven diagnostics. Collectively, these advancements have the potential to drastically reduce healthcare costs, enhance operational efficiency, and enable the delivery of higher quality care. As the healthcare industry continues to embrace big data analytics, the magnitude of the transformative impact and the vast business opportunities will become increasingly evident, revolutionizing the landscape for both providers and patients. Big Data in Healthcare Market: Key Insights The report delves into the current state of the big data in healthcare market and identifies potential growth opportunities within the industry. Some key findings from the report include: Big Data in Healthcare Market: Research Coverage Sample Players in the Big Data in Healthcare Market, Profiled in the Report, Include: Key Questions Answered in this Report Reasons to Buy this Report Additional Benefits For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: PROFESSIONAL SERVICES DATA MANAGEMENT HEALTH TECHNOLOGY DATA ANALYTICS OTHER HEALTH SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 08/07/2025 11:52 AM/DISC: 08/07/2025 11:51 AM
Khaleej Times
7 days ago
- Health
- Khaleej Times
Future of Healthcare Summit to gather top experts in Dubai
Senior healthcare leaders from across the region are set to convene in Dubai for the 5th Future of Healthcare Summit 2025. Under the theme 'Echoes of Tomorrow | Building the Future of Care,' the summit will showcase the UAE's commitment to transforming healthcare through innovation, technology and strategic collaboration. As the UAE reimagines its healthcare future in alignment with UAE Vision 2031, the summit emerges as a vital platform, not merely for dialogue but for decisive action. It will explore how advanced technologies such as AI, connected infrastructure, precision medicine and value-based care can be scaled responsibly, ensuring patient outcomes, access, and wellbeing remain at the heart of every transformation. In a special highlight, Khaleej Times will also unveil the UAE's top healthcare leaders, honouring individuals driving excellence, innovation and impact across the health sector. Future of Healthcare 2025 is designed to catalyse cross-sector collaboration. The event will convene senior leaders from ministries of health, private healthcare groups, digital health innovators, research institutions and strategic investors to shape sustainable, future-ready healthcare models tailored to the UAE's unique population needs and growth trajectory. The theme 'Echoes of Tomorrow | Building the Future of Care' serves as both a challenge and a call to action, reminding us that the healthcare decisions made today will reverberate for generations. In a country investing boldly in AI, smart cities, and health-tech ecosystems, the future of care is no longer conceptual; it is being actively engineered. KT Events is currently accepting speaker submissions from thought leaders driving transformation in digital health, patient experience, regulation and sustainable investment. Strategic sponsorship and media partnership opportunities are also available for brands seeking to align with the region's most influential healthcare decision-makers. As healthcare becomes central to the UAE's knowledge economy and technological leadership, the Future of Healthcare Summit 2025 stands as a landmark gathering, where global vision meets regional ambition and innovation leads the way forward. For those shaping the intersection of health, policy, and innovation in the UAE and beyond, this summit is a blueprint for the future of care.
Khaleej Times
05-08-2025
- Health
- Khaleej Times
AI, precision medicine: Future of Healthcare Summit 2025 to gather top experts in Dubai
Senior healthcare leaders from across the region are set to convene in Dubai for the 5th Future of Healthcare Summit 2025. Under the theme 'Echoes of Tomorrow | Building the Future of Care,' the summit will showcase the UAE's commitment to transforming healthcare through innovation, technology, and strategic collaboration. As the UAE reimagines its healthcare future in alignment with UAE Vision 2031, the summit emerges as a vital platform, not merely for dialogue, but for decisive action. It will explore how advanced technologies such as AI, connected infrastructure, precision medicine, and value-based care can be scaled responsibly, ensuring patient outcomes, access, and wellbeing remain at the heart of every transformation. In a special highlight, Khaleej Times will also unveil the UAE's Top Healthcare Leaders, honouring individuals driving excellence, innovation, and impact across the health sector. Future of Healthcare 2025 is designed to catalyze cross-sector collaboration. The event will convene senior leaders from ministries of health, private healthcare groups, digital health innovators, research institutions, and strategic investors to shape sustainable, future-ready healthcare models tailored to the UAE's unique population needs and growth trajectory. The theme 'Echoes of Tomorrow | Building the Future of Care' serves as both a challenge and a call to action, reminding us that the healthcare decisions made today will reverberate for generations. In a country investing boldly in AI, smart cities, and health-tech ecosystems, the future of care is no longer conceptual; it is being actively engineered. KT Events is currently accepting speaker submissions from thought leaders driving transformation in digital health, patient experience, regulation, and sustainable investment. Strategic sponsorship and media partnership opportunities are also available for brands seeking to align with the region's most influential healthcare decision-makers. As healthcare becomes central to the UAE's knowledge economy and technological leadership, the Future of Healthcare Summit 2025 stands as a landmark gathering, where global vision meets regional ambition, and innovation leads the way forward. For those shaping the intersection of health, policy, and innovation in the UAE and beyond, this summit is a blueprint for the future of care.
Yahoo
18-07-2025
- Business
- Yahoo
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche
German Biotechnology Market Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Germany Biotechnology Market Report and Forecast 2025-2034" has been added to Germany biotechnology market was valued at USD 35.30 Billion in 2024, bolstered by robust public and private investment in biotech innovation, alongside significant R&D endeavors supported by established academic and research institutions. The market is expected to grow at a CAGR of 10.30% during 2025-2034, potentially reaching USD 94.09 Billion by 2034. Government initiatives and funding play a critical role in accelerating the development and commercialization of advanced biotechnological solutions, contributing to market expansion. This growth is also underpinned by strong infrastructure, substantial R&D capabilities, and a skilled workforce. The increasing adoption of precision medicine and biopharmaceuticals is anticipated to further drive market growth in the forecast period. Increasing Prevalence of Chronic Diseases The market's growth is heavily influenced by the rising incidence of chronic and degenerative diseases. According to WHO data from 2021, conditions such as ischemic heart disease, Alzheimer's disease, stroke, various cancers, COPD, and kidney disorders impose a significant health burden, intensifying demand for innovative diagnostics, targeted therapies, and precision medicine. This drives forward the biotechnology sector, bolstered by increased research and development investments from both public and private sectors. Germany Biotechnology Market Trends Key trends include rising investments and the advent of cutting-edge, sustainable technologies. Investment confidence continues to grow, evidenced by a 78% increase in funding for German biotech firms, reaching EUR 1.917 billion in 2024, according to BIO Deutschland and EY. This capital influx is set to enhance market growth and technological progress. Additionally, innovative, eco-friendly food technologies are driving demand. In March 2024, the launch of Kynda's zero-waste mycelium-based food product in Germany highlighted a move towards sustainable consumer solutions, anticipating an increase in the market's growth and the adoption of sustainable biotech products. Germany Biotechnology Market Segmentation The market analysis includes segments such as: Product Type: Instruments, Reagents, Software and Services, Others Technology: Nanobiotechnology, Tissue Engineering, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography, Others Application: Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, Others Germany Biotechnology Market Share: DNA Sequencing's Impact The biotechnology market in Germany is diversified across various technologies, with DNA sequencing anticipated to lead. Innovations like Merck's Aptegra platform, which integrates multiple assays into one, significantly reduce testing times and costs, driving DNA sequencing's important role in the market's future growth. Leading Players in the Germany Biotechnology Market The major market players include: QIAGEN N.V: Expanded its portfolio by acquiring Genoox, enhancing AI-driven genetic data interpretation for clinical decision-making. Thermo Fisher Scientific, Inc: Introduced sustainable centrifuges in Germany, boosting energy efficiency in bioprocessing. Illumina Inc: Partnered with to launch an extensive clinical multiomic dataset, propelling advancements in metabolic disease therapies. F. Hoffman-La Roche Ltd: Gained FDA clearance for a dual mRNA probe assay improving B-cell lymphoma diagnostics. Other key companies include Evotec SE, Bio-Rad Laboratories, Agilent Technologies, and BioNTech SE. Key Questions Answered What was the Germany biotechnology market value in 2024? What is the forecast for 2025-2034? What drives demand in the market? How has the market performed historically, and future expectations? What are the major trends and challenges? Which product, technology, and application segments are expected to dominate? Who are the key players? Key Attributes Report Attribute Details No. of Pages 250 Forecast Period 2025-2034 Estimated Market Value (USD) in 2025 $35.3 Billion Forecasted Market Value (USD) by 2034 $94.09 Billion Compound Annual Growth Rate 10.3% Regions Covered Germany Key Topics Covered 1 Preface 1.1 Objectives of the Study 1.2 Key Assumptions 1.3 Report Coverage - Key Segmentation and Scope 1.4 Research Methodology 2 Executive Summary 3 Biotechnology Market Overview 3.1 Europe Biotechnology Market 3.2 Germany Biotechnology Market 4 Vendor Positioning Analysis 4.1 Key Vendors 4.2 Prospective Leaders 4.3 Niche Leaders 4.4 Disruptors 5 Germany Biotechnology Market Landscape 5.1 Germany Biotechnology Market: Developers Landscape 5.2 Germany Biotechnology Market: Product Landscape 6 Germany Biotechnology Market Dynamics 6.1 Market Drivers and Constraints 6.2 SWOT Analysis 6.3 PESTEL Analysis 6.4 Porter's Five Forces Model 6.5 Key Demand Indicators 6.6 Key Price Indicators 6.7 Industry Events, Initiatives, and Trends 6.8 Value Chain Analysis 7 Germany Biotechnology Market Segmentation (2018-2034) 7.1 By Product Type 7.2 By Technology 7.3 By Application 8 Regulatory Framework 9 Patent Analysis 10 Funding and Investment Analysis 11 Strategic Initiatives 12 Supplier Landscape 13 Germany Biotechnology Market - Distribution Model (Additional Insight) 14 Key Opinion Leaders (KOL) Insights (Additional Insight) For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment German Biotechnology Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Globe and Mail
14-07-2025
- Business
- Globe and Mail
Precision Diagnostics & Medicine Market worth $246.66 billion by 2029
"Key players in the Precision diagnostic market include F. Hoffman La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), and Guardant Health (US) among others and key players in precision medicine market include Merck Co, Inc. (US), Gilead Sciences (US), AstraZeneca (UK), Novartis AG (Switzerland), among others." Browse 416 market data Tables and 92 Figures spread through 445 Pages and in-depth TOC on "Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029 The report " Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029", is expected to reach USD 246.66 billion by 2029 from USD 145.53 billion in 2024, growing at a CAGR of 11.1% Factors such as the increasing integration of AI and ML for the development of advanced precision diagnostics and therapeutic solutions supported by the rising collaboration and investment by major pharmaceutical companies for the development of precision medicine and biomarker discovery drive the growth of the market. Moreover, the increasing demand for direct-to-consumer testing owing to the growing awareness of patients towards their health and the convenience offered by these tests supports the adoption of precision diagnostics. Additionally, the expanding focus of pharmaceutical companies on the development of precision solutions for other diseases such as neurodegenerative disorders and autoimmune diseases and the integration of wearable technology to enhance healthcare offers growth opportunities for players operating in the precision medicine market. However, factors such as the high cost of precision healthcare and the challenges related to the integration and management of big data in precision solution development restrain the growth of the market. Browse 416 market data Tables and 92 Figures spread through 445 Pages and in-depth TOC on "Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029"View detailed Table of Content here - The monoclonal antibodies segment accounted for the largest share of the Precision Medicine Market, by product, during the forecast period. Based on products, the precision medicine market is divided into inhibitor drugs, monoclonal antibodies, cell and gene therapy, antiviral and anti-retroviral drugs, and other therapeutic products. The large share of the monoclonal antibodies products segment can be attributed to the fact that a large number of the approved precision therapies are monoclonal antibodies. This large share of this segment is also supported by the ongoing approvals for monoclonal antibody drugs for various cancers and other diseases highlighting a focus of pharmaceutical companies on the development of monoclonal antibodies as precision medicines. The oncology subsegment accounted for the largest share of the precision diagnostics market's indication segment in 2023 Based on indication, the precision diagnostics market is segmented into oncology, neurology, immunology, and other indications. The oncology segment accounted for the largest share of the precision diagnostics market by indication in 2023. The large share of this segment is attributed to the increase in cancer cases globally, supported by rising demand for diagnostic tests offering early and accurate cancer diagnosis. For this reason, life science companies are increasingly investing and collaborating to develop advanced oncology diagnostic tests. This dominance is expected to continue throughout the forecast period as major players are developing new technologies for better oncology diagnosis. Asia Pacific is registered as the fastest-growing region of the Precision diagnostics market in 2023. The Precision medicine market is divided into five regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2023, North America held the largest share of the precision diagnostics market, followed by Europe. Aisa Pacific registered the highest CAGR growth within the precision diagnostics market during the forecast period. The expansion of key diagnostic players in the region followed by favorable policies supporting the larger adoption of precision medicine is a supporting factor. Additionally, there is a greater awareness about personalized approach to treatments in these developed regions compared to the developing/ emerging economies. Key players in the Precision diagnostic market include F. Hoffman La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), and Guardant Health (US) among others and key players in precision medicine market include Merck Co, Inc. (US), Gilead Sciences (US), AstraZeneca (UK), Novartis AG (Switzerland), among others. Don't miss out on business opportunities in Precision Diagnostics & Medicine Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
